You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II follicular thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Pathological Manifestation in Thyroid Follicular Neoplasm: Early

Not yet recruiting
  • Thyroid Cancer
  • Follicular Thyroid Cancer
    • (no location specified)
    Jul 20, 2022

    Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

    Active, not recruiting
    • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
    • +11 more
    • Washington, District of Columbia
    • +6 more
    Feb 2, 2023

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      Studies on Tumors of the Thyroid

      Recruiting
      • Hurthle Cell Thyroid Cancer
      • +4 more
      • 68-Gallium Dotatate
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

      Recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +5 more
      • Fresno, California
      • +2 more
      Jan 24, 2023

      Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

      Recruiting
      • Thyroid Cancer
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      Jan 19, 2023

      Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

      Active, not recruiting
      • Ann Arbor Stage I Grade 1 Follicular Lymphoma
      • +3 more
      • Clinical Observation
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

      Recruiting
      • Differentiated Thyroid Gland Carcinoma
      • +2 more
      • Computed Tomography
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

      Not yet recruiting
      • Thyroid Cancer
      • +5 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Dec 20, 2022

      Surgical Management of Advanced Thyroid Cancer

      Recruiting
      • Thyroid Carcinoma
      • +6 more
      • Thyroidectomy with or without lymphadenectomy or multivisceral resection
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 31, 2023

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

      Active, not recruiting
      • Ann Arbor Stage II Grade 1 Follicular Lymphoma
      • +12 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 18, 2022

      Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

      Not yet recruiting
      • Follicular Lymphoma Stage II
      • +2 more
      • Ballarat, Victoria, Australia
      • +4 more
      Mar 15, 2023

      Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

      Not yet recruiting
      • Thyroid Cancer
      • 20 mg Famitinib & 1200 mg Adebrelimab
      • (no location specified)
      Nov 26, 2023

      Thyroid Cancer Trial in Suita (Targeted alpha therapy)

      Recruiting
      • Thyroid Cancer
      • Targeted alpha therapy
      • Suita, Japan
        Osaka University Hospital
      Mar 2, 2022

      Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

      Recruiting
      • Thyroid Cancer
      • Chengdu, Sichuan, China
        Xingchen Peng
      Dec 17, 2022

      Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

      Recruiting
      • Refractory Thyroid Gland Carcinoma
      • +3 more
      • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
      • +2 more
      • Xiamen, China
        The First Affiliated Hospital of Xiamen University
      Nov 3, 2022

      Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

      Completed
      Has Results
      • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
      • +11 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Mountain View, California
      • +90 more
      Aug 3, 2022

      Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)

      Recruiting
      • Thyroid Cancer
      • +2 more
      • Beijing, Beijing, China
        Cancer Hospital, Chinese Academy of Medical Science
      Oct 13, 2023

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

      Active, not recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +9 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 3, 2022

      Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

      Not yet recruiting
      • Thyroid Neoplasm Follicular
      • Bone Metastases
      • Beijing, China
        Peking Union Medical College Hospital
      Jul 18, 2022

      Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

      Recruiting
      • Benign Thyroid Gland Neoplasm
      • +4 more
      • Quality-of-Life Assessment
      • Radiofrequency Ablation
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 3, 2022

      Thyroid Cancer Stage IV, Radiation Toxicity Trial in Mumbai (Intensity Modulated Radiotherapy, Surgery alone)

      Active, not recruiting
      • Thyroid Cancer Stage IV
      • Radiation Toxicity
      • Intensity Modulated Radiotherapy
      • Surgery alone
      • Mumbai, Maharashtra, India
        Gouri Pantvaidya
      Apr 29, 2022

      BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

      Recruiting
      • BRAF NP_004324.2:p.V600M
      • +6 more
      • Portland, Oregon
        Providence Portland Medical Center
      Aug 17, 2022